You are here

drug development

Amgen targets China in cancer biosimilar development deal with Simcere

Amgen targets China in cancer biosimilar development deal with Simcere

Fierce Pharma

drug development

Flag link:

WHO raises alarm on lack of new antibiotics

WHO raises alarm on lack of new antibiotics

GoInPharma

drug development

Flag link:

Alzheimer's drug development just as challenging as ever

Alzheimer's drug development just as challenging as ever

BioPharma Dive

drug development

Alzheimer's disease

Flag link:

Will an Open-Access Clinical Trials Database Improve Drug Development?

Will an Open-Access Clinical Trials Database Improve Drug Development?

Xtalks

clinical trials

clinical trial data

drug development

Flag link:

The race for a Zika vaccine slows, a setback for efforts to head off future outbreaks

The race for a Zika vaccine slows, a setback for efforts to head off future outbreaks

Stat

drug development

Flag link:

Study says drug development costs much less than previously estimated

Study says drug development costs much less than previously estimated

Medical Marketing and Media

drug development

Flag link:

Scott Gottlieb vows to shake up the FDA, backing a trend toward faster drug development

Scott Gottlieb vows to shake up the FDA, backing a trend toward faster drug development

Endpoints

drug development

Flag link:

Bioverativ and Bicycle keep rare disease deals rolling

Bioverativ and Bicycle keep rare disease deals rolling

BioPharma Dive

Bicycle Therapeutics

drug development

sickle cell disease

Flag link:

3SBio snaps up Therapure CDMO for $290M

3SBio snaps up Therapure CDMO for $290M

BioPharma Dive

drug development

Flag link:

Where are Drugs Invented, and Why Does it Matter?

Where are Drugs Invented, and Why Does it Matter?

Drug Patent Watch

drug development

Flag link:

Jazz, ImmunoGen partner on hematology, oncology drug development

Jazz, ImmunoGen partner on hematology, oncology drug development

BioPharma Dive

Jazz Pharmaceuticals

drug development

Flag link:

Samsung Bioepis switches gears, moves from knockoffs to new drugs with fast-changing Takeda

Samsung Bioepis switches gears, moves from knockoffs to new drugs with fast-changing Takeda

Endpoints

Samsung Bioepis

drug development

Flag link:

Roche, Mimetas develop “gut-on-a-chip” tech for drug-testing

Roche, Mimetas develop “gut-on-a-chip” tech for drug-testing

Drug Delivery Business News

drug development

Flag link:

New target could yield treatment for Alzheimer's, ALS and more

New target could yield treatment for Alzheimer's, ALS and more

Fierce Biotech

drug development

Alzheimer's disease

Flag link:

Drug developers face increasingly risky tightrope walk between top-line results and hard data

Drug developers face increasingly risky tightrope walk between top-line results and hard data

Endpoints

drug development

clinical trials

late stage data

Flag link:

5 Trends influencing drug pricing

5 Trends influencing drug pricing

BioPharma Dive

drug development

Flag link:

Takeda partners to develop novel oncology therapies

Takeda partners to develop novel oncology therapies

Drug Delivery Business News

Molecular Templates

drug development

Flag link:

Sanofi shifts focus to internal R&D as it preps an end to a stunningly effective Regeneron alliance

Sanofi shifts focus to internal R&D as it preps an end to a stunningly effective Regeneron alliance

Endpoints

drug development

Flag link:

5 trends shaping Alzheimer's drug development

5 trends shaping Alzheimer's drug development

BioPharma Dive

Alzheimer's disease

drug development

Flag link:

Hunt for enzymes heats up, a potential boon for biotech and beyond

Hunt for enzymes heats up, a potential boon for biotech and beyond

Stat

drug development

gene sequencing

Flag link: